These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6985888)

  • 21. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
    de Gaetano G; Cerletti C; Bertelè V
    Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
    Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
    Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
    Findlay JM; Lougheed WM; Gentili F; Walker PM; Glynn MF; Houle S
    J Neurosurg; 1985 Nov; 63(5):693-8. PubMed ID: 3903068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
    Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ
    N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs.
    Boudreaux MK; Dillon AR; Ravis WR; Sartin EA; Spano JS
    Am J Vet Res; 1991 Dec; 52(12):1992-9. PubMed ID: 1789513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
    Danese CA; Haimov M
    Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombotic thrombocytopenic purpura. Survival following treatment with aspirin, dipyridamole, and prednisone.
    Rossi EC; Redondo D; Borges WH
    JAMA; 1974 May; 228(9):1141-3. PubMed ID: 4406437
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiplatelet therapy and cerebrovascular diseases.
    Meloche JP
    Adv Otorhinolaryngol; 1982; 28():100-3. PubMed ID: 7051785
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
    Sinzinger H; O'Grady J; Fitscha P
    J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA
    Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of acetylsalicylic acid and dipyridamole on platelet economy in metastatic cancer.
    Abrahamsen AF
    Scand J Haematol; 1972; 9(6):562-5. PubMed ID: 4644420
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial.
    Hess H; Mietaschk A; Deichsel G
    Lancet; 1985 Feb; 1(8426):415-9. PubMed ID: 2857803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
    Chesebro JH; Clements IP; Fuster V; Elveback LR; Smith HC; Bardsley WT; Frye RL; Holmes DR; Vlietstra RE; Pluth JR; Wallace RB; Puga FJ; Orszulak TA; Piehler JM; Schaff HV; Danielson GK
    N Engl J Med; 1982 Jul; 307(2):73-8. PubMed ID: 7045659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of thromboembolic complications of valve prostheses by agents affecting platelet function.
    Wyss M; Diez C; Balavoine JF; Martin D; Bouvier CA
    Eur J Cardiol; 1978 Oct; 8(3):337-47. PubMed ID: 710491
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
    Gitler B; Gitler ES
    Am Heart J; 1983 Sep; 106(3):563-70. PubMed ID: 6410893
    [No Abstract]   [Full Text] [Related]  

  • 39. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.